[Complete response achieved in a case of gastric gastrointestinal stromal tumor by administration of imatinib mesilate with concurrent relatively high-dose steroid therapy to control side effects].

Author: KishimotoHirofumi, NakamuraMasato, OtagiriNoriaki, SasaharaKotaro, TauchiKatsunori, TsukadaYuichiro, YoshifukuSeijiro

Paper Details 
Original Abstract of the Article :
We present a 53-year-old man who underwent proximal gastrectomy for gastric gastrointestinal stromal tumor (GIST) in August 2005. Imatinib mesilate (imatinib) 400 mg/day was started in February 2006 for left adrenal metastasis. Tumor size markedly decreased by April 2006, but medication had to be di...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/21084823

データ提供:米国国立医学図書館(NLM)

Treating Gastric GIST with Imatinib and Steroids: A Case Study

The medical field is constantly evolving and finding new ways to fight cancer. This case report focuses on the treatment of a rare type of cancer called gastric gastrointestinal stromal tumor (GIST). The patient presented with a tumor in his stomach and later developed metastases in his adrenal gland. The primary treatment was imatinib mesilate, a drug that targets specific proteins involved in tumor growth. However, the patient experienced side effects like a pruritic rash, which forced a temporary discontinuation of the treatment. In the end, a combination therapy, using imatinib and steroids to control side effects, led to a complete response. The tumor was no longer visible on CT scans, indicating a remarkable success story.

The Power of Combination Therapy: A Team Effort

The effectiveness of the combination therapy, using imatinib and steroids, emphasizes the importance of a multi-faceted approach to cancer treatment. It's like having a team of skilled desert explorers, each with their unique expertise, working together to navigate a complex and challenging terrain. The success of this approach highlights the potential of combining different treatment strategies to achieve a complete response.

Hope and Resilience: A Journey of Recovery

This case report is a testament to the remarkable progress made in cancer treatment and the resilience of the human body. It offers hope to patients facing similar challenges, reminding them that even in the face of adversity, there is always reason to be hopeful. It's like watching a camel, with its unwavering determination, traverse the harsh desert landscape, enduring challenges and emerging triumphant.

Dr.Camel's Conclusion

The successful use of imatinib and steroids in treating a patient with gastric GIST highlights the importance of personalized medicine and the potential of combination therapies in cancer treatment. It's a reminder that even in the face of complex medical challenges, hope and perseverance can lead to remarkable outcomes.

Date :
  1. Date Completed 2011-01-03
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

21084823

DOI: Digital Object Identifier

21084823

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.